Fetal heart rate patterns and the incidence of adverse events after oral misoprostol administration for cervical ripening among low-risk pregnancies

References

• Morrish D, Hoskins IA. Induction of labor: review of pros, cons, and controversies. In: Childbirth. IntechOpen; 2020. DOI:10.5772/intechopen.89237
   Google Scholar
• Zhang J, Yancey MK, Henderson CE. U.S. national trends in labor induction, 1989–1998. J Reprod Med. 2002;47(2):120–124.
   PubMed Web of Science ®Google Scholar
• Martin J, Hamilton B, Osterman M, et al. Births: final data for 2018. Natl Vital Stat Rep. 2019;68(13):1–47.
   Google Scholar
• Moore LE, Rayburn WF. Elective induction of labor. Clin Obstet Gynecol. 2006;49(3):698–704.
   PubMed Web of Science ®Google Scholar
• Mathews TJ, Hamilton BE. Mean age of mothers is on the rise: United States, 2000–2014. NCHS Data Brief. 2016;232:1–8.
   Google Scholar
• Grobman WA. Is it time for outpatient cervical ripening with prostaglandins? BJOG. 2015;122(1):105–105.
   PubMed Web of Science ®Google Scholar
• Teixeira C, Lunet N, Rodrigues T, et al. The bishop score as a determinant of labour induction success: a systematic review and meta-analysis. Arch Gynecol Obstet. 2012;286(3):739–753.
   PubMed Web of Science ®Google Scholar
• Kouam L, Kamdom-Moyo J, Shasha W, et al. Induced labor: conditions for success and causes of failure. A prospective study of 162 cases. Rev Fr Gynecol Obstet. 1993;88(4):243–248.
   PubMedGoogle Scholar
• Keirse MJ. Prostaglandins in preinduction cervical ripening. Meta-analysis of worldwide clinical experience. J Reprod Med. 1993;38(1 Suppl):89–100.
   PubMed Web of Science ®Google Scholar
• Pierce S, Bakker R, Myers DA, et al. Clinical insights for cervical ripening and labor induction using prostaglandins. AJP Rep. 2018;8(4):e307–e314.
   PubMed Web of Science ®Google Scholar
• Rayburn WF. Preinduction cervical ripening: basis and methods of current practice. Obstet Gynecol Surv. 2002;57(10):683–692.
   PubMed Web of Science ®Google Scholar
• Allen R, O’Brien BM. Uses of misoprostol in obstetrics and gynecology. Rev Obstet Gynecol. 2009;2(3):159–168.
   PubMedGoogle Scholar
• Muzonzini G, Hofmeyr GJ. Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2004;2004(4):CD004221.
   PubMedGoogle Scholar
• Alfirevic Z, Aflaifel N, Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2014;13(6):CD001338.
   Google Scholar
• Kipikasa JH, Adair CD, Williamson J, et al. Use of misoprostol on an outpatient basis for postdate pregnancy. Int J Gynaecol Obstet. 2005;88(2):108–111.
   PubMed Web of Science ®Google Scholar
• Ramsey PS, Meyer L, Walkes BA, et al. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstet Gynecol. 2005;105(1):85–90.
   PubMed Web of Science ®Google Scholar
• Stephenson ML, Powers BL, Wing DA. Fetal heart rate and cardiotocographic abnormalities with varying dose misoprostol vaginal inserts. J Matern Fetal Neonatal Med. 2013;26(2):127–131.
   PubMed Web of Science ®Google Scholar
• Adelson PL, Wedlock GR, Wilkinson CS, et al. A cost analysis of inpatient compared with outpatient prostaglandin E2 cervical priming for induction of labour: results from the OPRA trial. Aust Health Rev. 2013;37(4):467–473.
   PubMed Web of Science ®Google Scholar
• Stitely ML, Browning J, Fowler M, et al. Outpatient cervical ripening with intravaginal misoprostol. Obstet Gynecol. 2000;96(5 Pt 1):684–688.
   PubMed Web of Science ®Google Scholar
• Amorosa JMH, Stone JL. Outpatient cervical ripening. Semin Perinatol. 2015;39(6):488–494.
   PubMed Web of Science ®Google Scholar
• Shetty A, Livingstone I, Acharya S, et al. A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term. BJOG. 2004;111(5):436–440.
   PubMed Web of Science ®Google Scholar
• Cheung PC, Yeo ELK, Wong KS, et al. Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstet Gynecol Scand. 2006;85(9):1128–1133.
   PubMed Web of Science ®Google Scholar
• Clark SL, Nageotte MP, Garite TJ, et al. Intrapartum management of category II fetal heart rate tracings: towards standardization of care. Am J Obstet Gynecol. 2013;209(2):89–97.
   PubMed Web of Science ®Google Scholar
• Robinson B, Nelson L. A review of the proceedings from the 2008 NICHD workshop on standardized nomenclature for cardiotocography. Rev Obstet Gynecol. 2008;1(4):186–192.
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 106: intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol. 2009;114(1):192–202.
   PubMedGoogle Scholar
• Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynecol Obstet. 2007;99: S160–S167.
   PubMed Web of Science ®Google Scholar
• Leach KK, Onysko M. How common is uterine tachysystole with fetal heart rate abnormalities when inducing labor with misoprostol? Evid-Based Pract. 2013;16(9):14.
   Google Scholar
• Nelson KB, Dambrosia JM, Ting TY, et al. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med. 1996;334(10):613–618.
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Gyte GM, Cuthbert A, et al. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2017;2(2):CD006066.
   PubMedGoogle Scholar
• Parer JT, Ikeda T. A framework for standardized management of intrapartum fetal heart rate patterns. Am J Obstet Gynecol. 2007;197(1):26.e1-6–26.e6.
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Practice Bulletins – Obstetrics. ACOG practice bulletin no. 107: induction of labor. Obstet Gynecol. 2009;114(2 Pt 1):386–397.
   PubMedGoogle Scholar